Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Weimin Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6859-4648; OpenAlex author ID A5100601148, A5124755999. Sources: OpenAlex.

Their work

Papers
37 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
80
Papers, trials and grants by year

2011: 3 papers · 2012: 6 papers · 2013: 7 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 3 papers · 2019: 2 papers · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 37

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study. Co-author DOI 10.1158/1055-9965.epi-25-1601↗
  3. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  4. HLA-A*02:01allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of theHLAvariation in PDAC Co-author DOI 10.1101/2024.08.29.24312704↗
  5. Poor dental health and risk of pancreatic cancer: a nationwide registry-based cohort study in Sweden, 2009-2016. Last author DOI 10.1038/s41416-022-02018-8↗
  6. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. Last author DOI 10.1002/ijc.33464↗
  7. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Last author DOI 10.1002/ijc.33617↗
  8. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Co-author DOI 10.1136/gutjnl-2019-319990↗
  9. Gastric Mucosal Abnormality and Risk of Pancreatic Cancer: A Population-Based Gastric Biopsy Cohort Study in Sweden. Last author DOI 10.1158/1055-9965.epi-21-0580↗
  10. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Co-author DOI 10.1158/1055-9965.epi-19-1027↗
  11. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Co-author DOI 10.1002/ijc.31866↗
  12. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. Co-author DOI 10.1016/j.envres.2018.11.027↗
  13. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Co-author DOI 10.1002/ijc.31146↗
  14. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort. Co-author DOI 10.1002/ijc.31797↗
  15. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Co-author DOI 10.1093/ije/dyx269↗
  16. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition… Last author DOI 10.1002/ijc.30590↗
  17. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Co-author DOI 10.1038/bjc.2017.14↗
  18. A prospective cohort study on poor oral hygiene and pancreatic cancer risk. Last author DOI 10.1002/ijc.29710↗
  19. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.30190↗
  20. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1373/clinchem.2015.238543↗
  21. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  22. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.27637↗
  23. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Co-author DOI 10.1002/ijc.27875↗
  24. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  25. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Co-author DOI 10.1038/bjc.2013.689↗
  26. Pancreatic cancer risk after loss of a child: a register-based study in Sweden during 1991-2009. Co-author DOI 10.1093/aje/kwt045↗
  27. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗
  28. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  29. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  30. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Co-author DOI 10.1002/ijc.26452↗
  31. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  32. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Co-author DOI 10.1038/bjc.2012.172↗
  33. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  34. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Coho… Co-author DOI 10.1158/1055-9965.epi-11-1139↗
  35. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  36. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1016/j.ejca.2011.02.007↗
  37. Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Co-author DOI 10.1093/annonc/mdr302↗

Closest collaborators

The 25 strongest of 80 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingru Yu · 7 shared papers, 2019–2022 · strength 0.87
  2. Matthias J. Löhr · 7 shared papers, 2015–2021 · strength 0.59
  3. Esther Molina‐Montes · 18 shared papers, 2011–2021 · strength 0.59
  4. Núria Malats · 6 shared papers, 2018–2024 · strength 0.52
  5. Alfredo Carrato · 6 shared papers, 2018–2024 · strength 0.52
  6. Francisco X. Real · 6 shared papers, 2018–2024 · strength 0.52
  7. Eric J. Duell · 18 shared papers, 2011–2018 · strength 0.45
  8. H. Bas Bueno-de-Mesquita · 16 shared papers, 2011–2018 · strength 0.42
  9. Elio Ríboli · 16 shared papers, 2011–2018 · strength 0.41
  10. Linda Sharp · 5 shared papers, 2018–2024 · strength 0.41
  11. Luis Muñoz‐Bellvís · 5 shared papers, 2018–2024 · strength 0.41
  12. J. Enrique Domínguez‐Muñoz · 5 shared papers, 2018–2024 · strength 0.41
  13. William Greenhalf · 5 shared papers, 2018–2024 · strength 0.41
  14. Christoph W. Michalski · 5 shared papers, 2018–2024 · strength 0.41
  15. Jorg H. Kleeff · 5 shared papers, 2018–2024 · strength 0.41
  16. Bo Kong · 5 shared papers, 2018–2024 · strength 0.41
  17. Tatjana Crnogorac‐Jurcevic · 5 shared papers, 2018–2024 · strength 0.41
  18. Thomas Mathias Gress · 5 shared papers, 2018–2024 · strength 0.41
  19. Aldo Scarpa · 5 shared papers, 2018–2024 · strength 0.41
  20. Eithne Costello · 5 shared papers, 2018–2024 · strength 0.41
  21. Malin Sund · 16 shared papers, 2011–2017 · strength 0.36
  22. Rita Teresa Lawlor · 4 shared papers, 2019–2024 · strength 0.35
  23. Jiaqi Huang · 6 shared papers, 2013–2018 · strength 0.32
  24. Paolo Vineis · 14 shared papers, 2011–2018 · strength 0.31
  25. Rudolf Kaaks · 12 shared papers, 2011–2018 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.